Indigenously built stroke device approved on domestic trial data, launch set for February 2026

5 months ago 1
ARTICLE AD BOX
The instrumentality  offers caller   anticipation  to the 1.7 cardinal  Indians who endure  strokes each   year, said Dileep Yavagal, prof  of Neurology and Neurosurgery, University of Miami, who was portion  of the planetary  trial.

The instrumentality offers caller anticipation to the 1.7 cardinal Indians who endure strokes each year, said Dileep Yavagal, prof of Neurology and Neurosurgery, University of Miami, who was portion of the planetary trial. | Photo Credit: Getty Images/iStockphoto

The indigenously developed Supernova stent retriever—approved successful India utilizing lone home objective proceedings data— is expected to beryllium manufactured successful the state and launched successful February 2026. The instrumentality is utilized to dainty terrible strokes by removing clots and restoring humor travel to the encephalon wrong 24 hours.

Developed by Gravity Medical Technology, its objective proceedings was led by the All-India Institute of Medical Sciences (AIIMS), Delhi. The Central Drugs Standard Control Organisation (CDSCO) has approved the device’s manufacturing and selling successful India aft the proceedings demonstrated bully information and efficacy outcomes. It is the archetypal clip a changeable instrumentality has been approved successful India based solely connected home objective proceedings data.

AIIMS Delhi was the nationalist coordinating centre and the pb enrolling tract of the GRASSROOT proceedings for the Supernova Stent.

“This proceedings is simply a turning constituent for changeable attraction successful India. Supernova stent showed beardown show successful real-world objective settings involving terrible changeable cases,” said Shailesh B. Gaikwad, prof and head, Department of Neuroimaging & Interventional Neuroradiology, AIIMS Delhi, and National Principal Investigator of the GRASSROOT Trial.

“The Supernova stent has shown fantabulous information and efficacy outcomes successful the attraction of terrible strokes,” according to findings published precocious successful the Journal of Neurointerventional Surgery (JNIS).

In the archetypal prospective multicentre thrombectomy (procedure to physically region a humor clot from a blocked artery) trial, the Supernova stent retriever achieved precocious palmy restoration of humor travel with encephalon bleed (3.1 per cent), mortality (9.4 per cent), and 50 per cent functional independency astatine 90 days.

The India proceedings was conducted crossed 8 centres. The instrumentality has already been utilized to dainty much than 300 patients successful Southeast Asia and volition present beryllium manufactured and made disposable successful India astatine affordable prices, offering caller anticipation to the 1.7 cardinal Indians who endure strokes each year, added Dileep Yavagal, prof of Neurology and Neurosurgery, University of Miami, who was portion of the planetary trial.

Shashvat M Desai, main exertion serviceman astatine Gravity Medical Technology, said the support reflects India’s quality to behaviour globally competitory trials. “The Supernova stent is tailored to India’s unsocial changeable profile, wherever strokes thin to hap astatine a younger age compared to Western populations. The instrumentality has already been utilized to dainty patients successful Southeast Asia, reinforcing its information and versatility,’’ helium said.

Published - December 20, 2025 07:26 p.m. IST

Read Entire Article